dc.contributor.author | Merrill, Douglas | en_US |
dc.date.accessioned | 2005-07-06T16:16:27Z | en_US |
dc.date.available | 2005-07-06T16:16:27Z | en_US |
dc.date.issued | 2005-07-06T16:16:27Z | en_US |
dc.identifier.uri | http://hdl.handle.net/1850/969 | en_US |
dc.description.abstract | Chairman Skelos, Senators Alesi, Nozzolio and Robach and other distinguished members of the
panel, thank you for this opportunity to speak with you today. Your task, to investigate the
business development challenges confronting New York State’s high-technology and
biotechnology industries, is both critical and timely. It is only through a careful analysis of the
State’s past investments and strategic policies that we will be able to identify our best practices,
and then armed with that knowledge, develop a comprehensive plan to provide New York
companies with a competitive edge in an increasingly competitive marketplace. | en_US |
dc.format.extent | 65831 bytes | en_US |
dc.format.mimetype | application/pdf | en_US |
dc.language.iso | en_US | en_US |
dc.relation.ispartofseries | Monroe County Office Building, Rochester, NY | en_US |
dc.relation.ispartofseries | January 28 2004 | en_US |
dc.subject | Biotechnology | en_US |
dc.subject | Business development challenges | en_US |
dc.subject | Confronting NY State | en_US |
dc.subject | High technology | en_US |
dc.subject | Investigate | en_US |
dc.title | Testimony to the New York State Senate.
Select "NextGen" Task Force on Economic Development and the Emerging Industries | en_US |
dc.type | Presentation | en_US |